Technology | May 15, 2014

Mobile App Provides Life-Saving Assistance For Cardiac Patients

CathMaps+ debuts in Boston at AARP's Health [email protected]+ Tech Expo

CathMaps+ App Cath Lab Patient Engagement Mobile Devices

May 15, 2014 — CathMaps demonstrated how mobile technology can provide emergency assistance and peace of mind to millions of Americans at risk for a cardiac event. The AARP Health [email protected]+ Tech Expo showcases the latest in digital health technology designed to improve quality of life. The event is part of AARP's [email protected]+ National Event in Boston, May 8-10.

CathMaps+ is the world's first mobile application for people with elevated risk of a cardiac incident — particularly those who have a history of cardiac issues — that integrates critical health history and medical records with an interactive map of catheterization facilities (cath labs) throughout the world. The app is also HIPPA compliant.

"With the levels of heart disease on the rise in the U.S., the medical community must remain vigilant in our efforts to provide patients with tools and information that can help improve the quality of their lives," says Jack Stroh, an interventional cardiologist at Robert Wood Johnson University Hospital and St. Peter's University Hospital in New Jersey, and advisor to CathMaps+.

Approximately 715,000 Americans have a heart attack each year, according to the Centers for Disease Control. Nearly 30 percent of those have already suffered a heart attach. The CathMaps+ app ensures that patients quickly locate and are directed to a medical facility with a catheterization lab — wherever they may be traveling. They can securely access and share their medical history with the lab staff, saving critical time in treatment. They can also give permission for their information to be shared with loved ones, caregivers or emergency professionals.

"As a life or death condition, the idea of suffering a repeat incident is an almost constant concern. This app offsets patient anxiety, giving them peace of mind as they go about their daily lives," says Danny Oberman, founder and CEO of CathMaps+. "We see this as a valuable tool for cardiologist and the medical community as well. The AARP Health [email protected]+ Tech Expo is the perfect event to debut the app in the U.S."

Oberman founded CathMaps+ following his own cardiac incident in 2013. He combined his experience of living with an elevated risk of heart attack with his technology expertise to create a tool that is easy to use and functional in an emergency, while alleviating anxiety for cardiac patients.

CathMaps+, an Israeli-based technology company, is owned by Kickstart LLC, and is available for most Android and iOS users. The app is available in English and Spanish, with additional languages releases throughout 2014. It may be purchased from the App Store and Google Play.

For more information: www.cathmaps.com

Related Content

New Alliance Announced Between Transcatheter Cardiovascular Therapeutics and VEITHsymposium
News | Cath Lab | June 20, 2019
VEITHsymposium and the Cardiovascular Research Foundation (CRF) announced an alliance between Transcatheter...
Novel Index Accurately Predicts PCI Success Post-Procedure Compared to Established Measurement Metrics
News | Cath Lab | June 19, 2019
Results from a comprehensive analysis demonstrate the effectiveness of measuring a non-hyperemic pressure ratio (NHPR...
Philips Healthcare, Volcano IVUS showing an implanted stent. IVUS might offer an alternative to contrast angiography in patients with acute kidney disease (AKD).
News | Cath Lab | June 14, 2019
June 14, 2019 – A late-breaking study examined the effects of intravascular ultrasound (IVUS) guided drug-eluting ste
Videos | Cath Lab | May 20, 2019
This is a walk through of the primary structural heart hybrid cath lab at...
Mobility May Predict Elderly Heart Attack Survivors' Repeat Hospital Stays
News | Cath Lab | April 23, 2019
Determining which elderly heart attack patients take longer to stand from a seated position and walk across a room may...
FDA Releases New Guidance on Medical Devices Containing Nitinol
News | Cath Lab | April 18, 2019
April 18, 2019 — The U.S.
Angiography shows a stenotic lesion in the mid right coronary artery, undilatable by standard high-pressure balloon angioplasty (inset, arrowheads). (B) Optical coherence tomography (OCT) cross-sectional (top) and longitudinal (bottom) images acquired before IVL and coregistered to the OCT lens (arrow in A) demonstrate severe near-circumferential calcification in the area of the stenosis. (C) Angiography demonstrates improvement in the area of stenosis after IVL lithoplasty.

Figure 2: Angiography demonstrates a stenotic lesion in the mid right coronary artery, undilatable by standard high-pressure balloon angioplasty (inset, arrowheads). (B) Optical coherence tomography (OCT) cross-sectional (top) and longitudinal (bottom) images acquired before IVL and coregistered to the OCT lens (arrow in A) demonstrate severe near-circumferential calcification (double-headed arrow) in the area of the stenosis. (C) Angiography demonstrates improvement in the area of stenosis after IVL (inset; note the cavitation bubbles generated by IVL [black arrows]). (D) OCT cross-sectional (top) and longitudinal (bottom) images acquired post-IVL and coregistered to the OCT lens (white arrow in C) demonstrate multiple calcium fractures and large acute luminal gain. (E) Angiography demonstrates complete stent expansion with the semicompliant stent balloon (inset) without the need for high-pressure noncompliant balloon inflation. (F) OCT cross-sectional (top) and longitudinal (bottom) images acquired post-stenting and coregistered to the OCT lens (arrow in E) demonstrate further fracture displacement (arrow), with additional increase in the acute area gain (5.17 mm2), resulting in full stent expansion and minimal malapposition.

Feature | Cath Lab | April 15, 2019 | Dean Kereiakes, M.D., FACC, FSCAI, and Jonathan Hill, M.D., DISRUPT CAD III Co-Principal Investigators
Over the last 40 years, despite multiple advancements in percutaneous coronary interventions, calcified lesions remai
BIOTRONIK’s PK Papyrus covered coronary stent. The stent ius used in emergency coronary artery dissections to repair the vessel wall.
Technology | Cath Lab | April 15, 2019
April 15, 2019 — Biotronik began its U.S.
Overlay Init